Bank of America
RCUS icon

Bank of America’s Arcus Biosciences RCUS Stock Holding History

Bank of America’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,000
Closed -$37.8K – 8390
2024
Q1 		$37.8K Hold
2,000
– – ﹤0.01% 6595
2023
Q4 		$38.2K Hold
2,000
– – ﹤0.01% 6668
2023
Q3 		$35.9K Buy
+2,000
New +$40.2K ﹤0.01% 6586

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Bank of America's RCUS Position: Q1 2026 in Review

Bank of America reduced its Arcus Biosciences (RCUS) stake by 35% in Q1 2026, selling an estimated $7.66M and leaving 646,068 shares worth $14M. The position accounts for ﹤0.01% of the portfolio, ranked #2698.

Bank of America first reported a position in RCUS in Q1 2018 and has held it in 33 quarters since. The position peaked at $23.8M in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Bank of America held 646,068 shares of Arcus Biosciences worth $14M as of Q1 2026.
  • Bank of America sold 354,750 Arcus Biosciences shares in Q1 2026, an estimated $7.66M.
  • Arcus Biosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2698 holding.
  • Bank of America first reported a position in Arcus Biosciences in Q1 2018 and has held it in 33 quarters since.
  • Bank of America's Arcus Biosciences position peaked at $23.8M in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.